• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缓释药物递送系统给药后药物向玻璃体扩散的隔室及COMSOL多物理场3D建模

Compartmental and COMSOL Multiphysics 3D Modeling of Drug Diffusion to the Vitreous Following the Administration of a Sustained-Release Drug Delivery System.

作者信息

Dosmar Emily, Vuotto Gabrielle, Su Xingqi, Roberts Emily, Lannoy Abigail, Bailey Garet J, Mieler William F, Kang-Mieler Jennifer J

机构信息

Department of Biology and Biomedical Engineering, Rose-Hulman Institute of Technology, 5500 Wabash Avenue, Terre Haute, IN 47803, USA.

Department of Biomedical Engineering, Illinois Institute of Technology, 10 W 35th St., Chicago, IL 60616, USA.

出版信息

Pharmaceutics. 2021 Nov 4;13(11):1862. doi: 10.3390/pharmaceutics13111862.

DOI:10.3390/pharmaceutics13111862
PMID:34834276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8624029/
Abstract

The purpose of this study was to examine antibiotic drug transport from a hydrogel drug delivery system (DDS) using a computational model and a 3D model of the eye. Hydrogel DDSs loaded with vancomycin (VAN) were synthesized and release behavior was characterized in vitro. Four different compartmental and four COMSOL models of the eye were developed to describe transport into the vitreous originating from a DDS placed topically, in the subconjunctiva, subretinally, and intravitreally. The concentration of the simulated DDS was assumed to be the initial concentration of the hydrogel DDS. The simulation was executed over 1500 and 100 h for the compartmental and COMSOL models, respectively. Based on the MATLAB model, topical, subconjunctival, subretinal and vitreous administration took most (~500 h to least (0 h) amount of time to reach peak concentrations in the vitreous, respectively. All routes successfully achieved therapeutic levels of drug (0.007 mg/mL) in the vitreous. These models predict the relative build-up of drug in the vitreous following DDS administration in four different points of origin in the eye. Our model may eventually be used to explore the minimum loading dose of drug required in our DDS leading to reduced drug use and waste.

摘要

本研究的目的是使用计算模型和眼部三维模型,研究水凝胶药物递送系统(DDS)中抗生素药物的转运情况。合成了负载万古霉素(VAN)的水凝胶DDS,并对其体外释放行为进行了表征。开发了四种不同的眼部房室模型和四种COMSOL模型,以描述药物从局部、结膜下、视网膜下和玻璃体内放置的DDS转运至玻璃体的情况。模拟的DDS浓度假定为水凝胶DDS的初始浓度。房室模型和COMSOL模型的模拟时间分别为1500小时和100小时。基于MATLAB模型,局部、结膜下、视网膜下和玻璃体给药分别在玻璃体中达到峰值浓度所需的时间最多(约500小时)至最少(0小时)。所有给药途径均成功在玻璃体中达到了治疗药物水平(0.007mg/mL)。这些模型预测了在眼部四个不同起始点给予DDS后药物在玻璃体中的相对蓄积情况。我们的模型最终可能用于探索我们的DDS中所需的最小药物负载剂量,从而减少药物使用和浪费。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/24e8ee18f469/pharmaceutics-13-01862-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/e9de0a17ca5d/pharmaceutics-13-01862-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/147e1ebe2fde/pharmaceutics-13-01862-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/2df0a2a47df4/pharmaceutics-13-01862-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/e580a56facd4/pharmaceutics-13-01862-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/897121a9b8bf/pharmaceutics-13-01862-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/3f0fb5bd5baa/pharmaceutics-13-01862-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/e491e0e6a2d7/pharmaceutics-13-01862-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/c7a81a52ea66/pharmaceutics-13-01862-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/24e8ee18f469/pharmaceutics-13-01862-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/e9de0a17ca5d/pharmaceutics-13-01862-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/147e1ebe2fde/pharmaceutics-13-01862-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/2df0a2a47df4/pharmaceutics-13-01862-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/e580a56facd4/pharmaceutics-13-01862-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/897121a9b8bf/pharmaceutics-13-01862-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/3f0fb5bd5baa/pharmaceutics-13-01862-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/e491e0e6a2d7/pharmaceutics-13-01862-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/c7a81a52ea66/pharmaceutics-13-01862-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/8624029/24e8ee18f469/pharmaceutics-13-01862-g009.jpg

相似文献

1
Compartmental and COMSOL Multiphysics 3D Modeling of Drug Diffusion to the Vitreous Following the Administration of a Sustained-Release Drug Delivery System.缓释药物递送系统给药后药物向玻璃体扩散的隔室及COMSOL多物理场3D建模
Pharmaceutics. 2021 Nov 4;13(11):1862. doi: 10.3390/pharmaceutics13111862.
2
Ocular Pharmacokinetics of Brimonidine Drug Delivery System in Monkeys and Translational Modeling for Selection of Dose and Frequency in Clinical Trials.在猴子体内溴莫尼定药物传递系统的眼部药代动力学及临床试验中剂量和频率选择的转化模型。
J Pharmacol Exp Ther. 2021 Sep;378(3):207-214. doi: 10.1124/jpet.120.000483. Epub 2021 Jul 1.
3
Safety and Biocompatibility of Aflibercept-Loaded Microsphere Thermo-Responsive Hydrogel Drug Delivery System in a Nonhuman Primate Model.载阿柏西普微球热响应水凝胶药物递送系统在非人灵长类动物模型中的安全性和生物相容性
Transl Vis Sci Technol. 2020 Feb 27;9(3):30. doi: 10.1167/tvst.9.3.30.
4
Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In Vitro.可生物降解微球-水凝胶眼部药物传递系统,用于体外控制和延长生物活性阿柏西普的释放。
Curr Eye Res. 2019 Mar;44(3):264-274. doi: 10.1080/02713683.2018.1533983. Epub 2018 Oct 19.
5
Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration.用于治疗湿性年龄相关性黄斑变性的药物输送的实验和数学方法。
J Control Release. 2023 Nov;363:464-483. doi: 10.1016/j.jconrel.2023.09.021. Epub 2023 Oct 4.
6
Controlled Release of Vancomycin From a Thermoresponsive Hydrogel System for the Prophylactic Treatment of Postoperative Acute Endophthalmitis.万古霉素从热响应水凝胶系统中的控释用于术后急性眼内炎的预防性治疗
Transl Vis Sci Technol. 2019 Jun 27;8(3):53. doi: 10.1167/tvst.8.3.53. eCollection 2019 May.
7
[A pharmacodynamics study of an intravitreal amphotericin B drug delivery system for the treatment of experimental Aspergillus fumigatus endophthalmitis].[玻璃体内注射两性霉素B药物递送系统治疗实验性烟曲霉性眼内炎的药效学研究]
Zhonghua Yan Ke Za Zhi. 2007 Jun;43(6):546-53.
8
In Vivo Efficacy of an Injectable Microsphere-Hydrogel Ocular Drug Delivery System.可注射微球-水凝胶眼用药物递送系统的体内疗效
Curr Eye Res. 2017 Sep;42(9):1293-1301. doi: 10.1080/02713683.2017.1302590. Epub 2017 May 30.
9
Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.眼部植入物的药物控释:使用动态三维磁共振成像的评估
Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2722-31. doi: 10.1167/iovs.04-0091.
10
Design of Hollow Hyaluronic Acid Cylinders for Sustained Intravitreal Protein Delivery.中空透明质酸圆柱设计用于持续眼内蛋白递药。
J Pharm Sci. 2018 Sep;107(9):2354-2365. doi: 10.1016/j.xphs.2018.04.024. Epub 2018 May 3.

引用本文的文献

1
Smart molecules in ophthalmology: Hydrogels as responsive systems for ophthalmic applications.眼科中的智能分子:作为眼科应用响应系统的水凝胶
Smart Mol. 2024 Mar 15;2(1):e20230021. doi: 10.1002/smo.20230021. eCollection 2024 Mar.
2
A First-Passage Model of Intravitreal Drug Delivery and Residence Time-Influence of Ocular Geometry, Individual Variability, and Injection Location.眼内药物输送和驻留时间的首次通过模型——眼几何形状、个体差异和注射位置的影响。
Invest Ophthalmol Vis Sci. 2024 Oct 1;65(12):21. doi: 10.1167/iovs.65.12.21.
3
Unraveling Drug Delivery from Cyclodextrin Polymer-Coated Breast Implants: Integrating a Unidirectional Diffusion Mathematical Model with COMSOL Simulations.

本文引用的文献

1
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations.眼部后段给药:生物药剂学和药代动力学考量
Pharmaceutics. 2020 Mar 16;12(3):269. doi: 10.3390/pharmaceutics12030269.
2
Controlled Release of Vancomycin From a Thermoresponsive Hydrogel System for the Prophylactic Treatment of Postoperative Acute Endophthalmitis.万古霉素从热响应水凝胶系统中的控释用于术后急性眼内炎的预防性治疗
Transl Vis Sci Technol. 2019 Jun 27;8(3):53. doi: 10.1167/tvst.8.3.53. eCollection 2019 May.
3
Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.
解析环糊精聚合物涂层乳房植入物的药物递送:将单向扩散数学模型与COMSOL模拟相结合
Pharmaceutics. 2024 Apr 2;16(4):486. doi: 10.3390/pharmaceutics16040486.
4
Hydrogels in Ophthalmology: Novel Strategies for Overcoming Therapeutic Challenges.眼科水凝胶:克服治疗挑战的新策略。
Materials (Basel). 2023 Dec 23;17(1):86. doi: 10.3390/ma17010086.
5
Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration.用于治疗湿性年龄相关性黄斑变性的药物输送的实验和数学方法。
J Control Release. 2023 Nov;363:464-483. doi: 10.1016/j.jconrel.2023.09.021. Epub 2023 Oct 4.
6
Nano-composite system of traditional Chinese medicine for ocular applications: molecular docking and three-dimensional modeling insight for intelligent drug evaluation.中药眼用纳米复合系统:智能药物评价的分子对接和三维建模研究
Drug Deliv Transl Res. 2023 Dec;13(12):3132-3144. doi: 10.1007/s13346-023-01376-x. Epub 2023 Jun 25.
7
Biomembrane-Based Nanostructure- and Microstructure-Loaded Hydrogels for Promoting Chronic Wound Healing.基于生物膜的纳米结构和微结构负载水凝胶促进慢性伤口愈合。
Int J Nanomedicine. 2023 Jan 19;18:385-411. doi: 10.2147/IJN.S387382. eCollection 2023.
8
Vitreous Substitutes as Drug Release Systems.玻璃体替代物作为药物释放系统。
Transl Vis Sci Technol. 2022 Sep 1;11(9):14. doi: 10.1167/tvst.11.9.14.
机制性眼部吸收建模和模拟在理解制剂特性对兔眼部生物利用度影响中的应用:以地塞米松混悬剂为例的研究
AAPS J. 2019 May 20;21(4):65. doi: 10.1208/s12248-019-0334-x.
4
In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye.用于研究眼后段药物递送障碍的体外和离体模型。
Adv Drug Deliv Rev. 2018 Feb 15;126:44-57. doi: 10.1016/j.addr.2017.09.007. Epub 2017 Sep 19.
5
Subretinal Injection: A Review on the Novel Route of Therapeutic Delivery for Vitreoretinal Diseases.视网膜下注射:玻璃体视网膜疾病治疗性给药新途径综述
Ophthalmic Res. 2017;58(4):217-226. doi: 10.1159/000479157. Epub 2017 Sep 1.
6
Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications.用于眼前段和眼后段的长效眼部给药系统:生物材料的选择与应用
Expert Opin Drug Deliv. 2017 May;14(5):611-620. doi: 10.1080/17425247.2016.1227785. Epub 2016 Sep 1.
7
Ocular Drug Distribution After Topical Administration: Population Pharmacokinetic Model in Rabbits.局部给药后的眼内药物分布:家兔群体药代动力学模型
Eur J Drug Metab Pharmacokinet. 2017 Feb;42(1):59-68. doi: 10.1007/s13318-016-0319-4.
8
A Mechanistic Model of the Intravitreal Pharmacokinetics of Large Molecules and the Pharmacodynamic Suppression of Ocular Vascular Endothelial Growth Factor Levels by Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration.新生血管性年龄相关性黄斑变性患者玻璃体内大分子药物动力学的机制模型及雷珠单抗对眼血管内皮生长因子水平的药效学抑制作用
Mol Pharm. 2016 Sep 6;13(9):2941-50. doi: 10.1021/acs.molpharmaceut.5b00849. Epub 2016 Jan 14.
9
Controlled and Extended Release of a Model Protein from a Microsphere-Hydrogel Drug Delivery System.模型蛋白从微球-水凝胶药物递送系统中的可控和缓释
Ann Biomed Eng. 2015 Nov;43(11):2609-17. doi: 10.1007/s10439-015-1314-7. Epub 2015 Apr 3.
10
Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds as a cell delivery vehicle: characterization of PC12 cell response.可水解降解的聚乙二醇水凝胶支架作为细胞递送载体:PC12细胞反应的表征
Biotechnol Prog. 2013 Sep-Oct;29(5):1255-64. doi: 10.1002/btpr.1761. Epub 2013 Jun 22.